Hematology-Oncology
Navigating the Decision to Transplant Before Cancer Develops: A New Framework for RUNX1 Familial Platelet Disorder
Researchers present a pioneering preemptive hematopoietic stem cell transplantation approach for RUNX1-FPD, a hereditary disorder carrying a 35-50% lifetime risk of blood cancer, introducing a shared decision-making framework to guide this
